HEPA
Hepion Pharmaceuticals, Inc.
Key Financials
Net Income
$-8277850
↑ 37.3%
Operating Income
$-4163691
↑ 78.5%
Total Assets
$3.1M
↑ 90.2%
Revenue
$0
NaN%
Shareholders' Equity
$2.7M
↑ 243.2%
Total Liabilities
$402405.00
↓ 88.4%
Cash & Equivalents
$13.9M
↑ 391.6%
EPS (Diluted)
$-0.88
↑ 99.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/14/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 8-K | 3/18/2026 | View on SEC |
| 10-K | 3/12/2026 | View on SEC |
| 8-K | 3/3/2026 | View on SEC |
| 8-K | 1/15/2026 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
| SCHEDULE 13G/A | 8/14/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HEPA |
| Company Name | Hepion Pharmaceuticals, Inc. |
| CIK | 1583771 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 732-902-4000 |